APPLICATION OF COMBINED DRUG OF RECOMBINANT FOLLICULE-STIMULATING HORMONE/LUTEINIZING HORMONE IN PROGRAMS OF ASSISTED REPRODUCTIVE TECHNOLOGIES
Infertility treatment using assisted reproductive technologies in the majority of cases involving the use of various ovarian stimulation protocols to obtain the optimal number of oocytes and embryos.The use of analogues of gonadotropin-releasing hormone in ART programs prevents the synthesis of endo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1436 |
| Summary: | Infertility treatment using assisted reproductive technologies in the majority of cases involving the use of various ovarian stimulation protocols to obtain the optimal number of oocytes and embryos.The use of analogues of gonadotropin-releasing hormone in ART programs prevents the synthesis of endogenous gonadotropins, which is necessary for controlled ovarian stimulation to prevent premature luteinization and obtaining mature oocytes. Although the role of luteinizing hormone (LH) in the process of maturation of follicles and oocytes is not in doubt, the prescription of LH-containing preparations for ovarian stimulation should be performed after individual analysis of clinical and anamnesis data of the patient data and laboratory tests. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |